MEGA GENOMICS (06667) announced its performance in 2024, achieving a net profit of 45 million yuan, a year-on-year increase of 50.0%.

MEGA GENOMICS (06667) announced its performance for 2024, achieving operating income of approximately 164 million yuan, an increase of 8.5% year-on-year. Net profit reached 45 million yuan, an increase of 50.0% year-on-year. Earnings per share were 0.22 yuan. The announcement stated that this was mainly due to the company's persistence in product design innovation, continuous enrichment of its product matrix, optimization of product structure, and the adoption of proactive market expansion strategies. The company continues to explore more sales scenarios and channels, constantly exploring potential market demand and sales opportunities, building a diversified sales system, further enhancing customer service experience, and driving steady growth in revenue and net profit.